Life Sciences
An initial pilot scheme will provide patients with access to local community pharmacists via the Push Doctor platform.
Asset Management Ventures' Skip Fleshman outlines COVID-19's impact on clinical trials and the resulting leap toward tech-enabled decentralized trials.
The results will not impact the current rollout of a new version of the app, under special FDA guidelines.
It's been quite a year for digital, from Akili's de novo clearance to the downfall of 'digital pill' maker Proteus. MobiHealthNews takes a look back at the highlights.
Mark Treshock, blockchain solutions leader for healthcare and life sciences at IBM discusses how the technology can be used to validate vaccine supply chain and personal records.
Yesterday at Bayer G4A summit a panel of startup execs came together to discuss the future of femtech and its role in improving research into women's health.
The life science company created an initiative called the G4A Digital Health Partnership Program, which provides resources to both experienced and new digital health companies.
At a recent online event, Novartis Chief Digital Officer Betrand Bodson gave an update on a digital strategy that began in 2018.
The pharma giant is collaborating with sports tech firm Supersapiens.
The paper discusses the potenital for collecting real-world data, recruiting patients and using APIs.